PharmEnable
pharmenabletx.com
Actively hiring
Drug Discovery
Health Care
Pharmaceuticals
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
PharmEnable combines medicinal chemistry expertise with machine learning to find drug candidates for challenging protein targets. Founded in 2018 as a University of Cambridge spin-out, its Discovery Engine explores unusual chemical space that standard screening libraries miss. The company runs partnered programmes in neurology and oncology.
News
PharmEnable appoints Professor Jackie Hunter CBE as Corporate Advisor
We're delighted to welcome Professor Jackie Hunter CBE as Corporate Advisor to PharmEnable. Jackie's deep experience in pharma R&D, strategic partnerships and AI-driven innovation will be invaluable as PharmEnable advances its pipeline and collaborations.
Read more
Report
10 Cambridge AI spinouts
Meet 10 Cambridge spinouts, all hoping to harness the potential of AI for the good of the planet and its people.
Read more
Report
10 Cambridge spinouts changing the story of cancer
Meet 10 Cambridge spinouts, all putting their research into practice to improve patient outcomes.
Read more
Report
Clinical oncology pioneer joins PharmEnable's board
Exciting news at PharmEnable: we are proud to welcome Dr Ian Collins to our board as a new non-executive director. With three decades of experience in drug discovery and drug development, Ian will support our mission to push the boundaries of what is poss
Read more
Report
PharmEnable Therapeutics and Sosei Heptares Expand Drug Discovery Collaboration
PharmEnable Therapeutics and Sosei Heptares Expand Drug Discovery Collaboration The collaboration combines Sosei Heptares' leading structure-based drug design platform with PharmEnable's advanced artificial intelligence-enabled platform for designing high
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.